Chlorogenic acids have been associated with a decreased risk of type 2 diabetes (T2D); they hydrolyse to caffeic acid, which reduces glucose absorption and oxidative stress in vitro and inhibits glucose-6-phosphate translocase, thereby decreasing glucose output in the liver. Here, SLC37A4 is linked to type 2 diabetes mellitus.